Simple
Advanced Search
Field Combination
Cross Lingual Expansion
Chemical compounds (login required)

Browse by Week (PCT)
Gazette Archive
Sequence listing
National Phase Entries
National Phase Entries Full download
National Phase Entries Incremental download (last 7 days)
Authority File
Authority File Download Standard ST37
Authority File Download current year
Authority File Download All

WIPO Translate
WIPO Pearl
IPC Green Inventory
Portal to patent registers

Settings

Query
Office
Result
Download
Interface

Query Language

Stemming

Single Family Member

Include NPL

Sort by:

List Length

Result List View

Feedback

Please let us know your thoughts on PATENTSCOPE or tell us what you feel is missing or how we could improve it.

Your feedback

Contact email

Goto Application

Application Id/Number

1. WO2014086924 - COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY

PCT Biblio. Data
Description
Claims
National Phase
Patent Family
Notices
Documents

PermaLink

Machine translation
- WIPO Translate

Publication Number WO/2014/086924

Publication Date 12.06.2014

International Application No. PCT/EP2013/075661

International Filing Date 05.12.2013

IPC

C07D 453/02 2006.1

C	CHEMISTRY; METALLURGY
07	ORGANIC CHEMISTRY
D	HETEROCYCLIC COMPOUNDS
453	Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
02	containing not further condensed quinuclidine ring systems

C07D 453/02 2006.1

C	CHEMISTRY; METALLURGY
07	ORGANIC CHEMISTRY
D	HETEROCYCLIC COMPOUNDS
453	Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
02	containing not further condensed quinuclidine ring systems

View less classifications

CPC

A61K 31/439

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31	Medicinal preparations containing organic active ingredients
33	Heterocyclic compounds
395	having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435	having six-membered rings with one nitrogen as the only ring hetero atom
439	the ring forming part of a bridged ring system, e.g. quinuclidine

A61K 31/4709

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31	Medicinal preparations containing organic active ingredients
33	Heterocyclic compounds
395	having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435	having six-membered rings with one nitrogen as the only ring hetero atom
47	Quinolines; Isoquinolines
4709	Non-condensed quinolines and containing further heterocyclic rings

A61K 45/06

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45	Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
06	Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

A61K 9/0073

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9	Medicinal preparations characterised by special physical form
0012	Galenical forms characterised by the site of application
007	Pulmonary tract; Aromatherapy
0073	Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy;

A61K 9/12

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9	Medicinal preparations characterised by special physical form
10	Dispersions; Emulsions
12	Aerosols; Foams

A61M 11/005

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
M	DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY
11	Sprayers or atomisers specially adapted for therapeutic purposes
005	using ultrasonics

View more classifications

A61K 31/439

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31	Medicinal preparations containing organic active ingredients
33	Heterocyclic compounds
395	having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435	having six-membered rings with one nitrogen as the only ring hetero atom
439	the ring forming part of a bridged ring system, e.g. quinuclidine

A61K 31/4709

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31	Medicinal preparations containing organic active ingredients
33	Heterocyclic compounds
395	having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435	having six-membered rings with one nitrogen as the only ring hetero atom
47	Quinolines; Isoquinolines
4709	Non-condensed quinolines and containing further heterocyclic rings

A61K 45/06

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45	Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
06	Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

A61K 9/0073

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9	Medicinal preparations characterised by special physical form
0012	Galenical forms characterised by the site of application
007	Pulmonary tract; Aromatherapy
0073	Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy;

A61K 9/12

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
K	PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9	Medicinal preparations characterised by special physical form
10	Dispersions; Emulsions
12	Aerosols; Foams

A61M 11/005

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
M	DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY
11	Sprayers or atomisers specially adapted for therapeutic purposes
005	using ultrasonics

A61M 15/003

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
M	DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY
15	Inhalators
0028	using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
003	using capsules, e.g. to be perforated or broken-up

A61M 15/0045

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
M	DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY
15	Inhalators
0028	using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
0045	using multiple prepacked dosages on a same carrier, e.g. blisters

A61M 15/0065

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
M	DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY
15	Inhalators
0065	Inhalators with dosage or measuring devices

A61M 15/009

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
M	DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY
15	Inhalators
009	using medicine packages with incorporated spraying means, e.g. aerosol cans

A61M 16/14

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
M	DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY
16	Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
10	Preparation of respiratory gases or vapours
14	by mixing different fluids, one of them being in a liquid phase

A61M 2202/064

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
M	DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY
2202	Special media to be introduced, removed or treated
06	Solids
064	Powder

A61P 11/00

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
P	SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
11	Drugs for disorders of the respiratory system

A61P 29/00

A	HUMAN NECESSITIES
61	MEDICAL OR VETERINARY SCIENCE; HYGIENE
P	SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29	Non-central analgesic, antipyretic or anti-inflammatory agents, e.g antirheumatic agents; Non-steroidal anti-inflammatory drugs (NSAIDs)

C07D 215/38

C	CHEMISTRY; METALLURGY
07	ORGANIC CHEMISTRY
D	HETEROCYCLIC COMPOUNDS
215	Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
02	having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
16	with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
38	Nitrogen atoms

C07D 453/02

C	CHEMISTRY; METALLURGY
07	ORGANIC CHEMISTRY
D	HETEROCYCLIC COMPOUNDS
453	Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
02	containing not further condensed quinuclidine ring systems

View less classifications

Applicants

CHIESI FARMACEUTICI S.P.A. [IT]/[IT]

Inventors

RANCATI, Fabio
LINNEY, Ian

Agents

MINOJA, Fabrizio

Priority Data

12195891.2

06.12.2012

Publication Language English (en)

Filing Language English (EN)

Designated States

View all

AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)

Hide all

Title

(EN) COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY

(FR) COMPOSÉS AYANT UNE ACTIVITÉ ANTAGONISTE DU RÉCEPTEUR MUSCARINIQUE ET AGONISTE DU RÉCEPTEUR BÊTA2 ADRÉNERGIQUE

Abstract

(EN) The present invention relates to compounds acting both as muscarinic receptor antagonists and beta2 adrenergic receptor agonists, to processes for their preparation, to compositions comprising them, to therapeutic uses and combinations with other pharmaceutical active ingredients.

(FR) La présente invention concerne des composés agissant à la fois en tant qu'antagonistes du récepteur muscarinique et agonistes du récepteur bêta2 adrénergique, des procédés pour leur préparation, des compositions les comprenant, des utilisations thérapeutiques et des combinaisons avec d'autres principes pharmaceutiquement actifs.

Processing

National Phase Entries

Authority File

Settings

Feedback

Goto Application

1. WO2014086924 - COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY